Alector (ALEC) Free Cash Flow (2018 - 2026)
Alector (ALEC) posted quarterly Free Cash Flow of -$49.8 million for Q1 2026, up 18.03% year-over-year from -$42.2 million in Q1 2025, and down 19.44% quarter-over-quarter from -$41.7 million in Q4 2025.
Alector (ALEC) Free Cash Flow (2018 - 2026) Analysis & Trends
Alector (ALEC) has reported Free Cash Flow for 9 consecutive years, with -$49.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Free Cash Flow rose 18.03% year-over-year to -$49.8 million; the TTM figure through Mar 2026 stood at -$173.1 million (up 24.76% YoY), while the FY2025 annual figure was -$184.1 million, up 20.37% from the prior year.
- Free Cash Flow declined to -$49.8 million in Q1 2026 per ALEC's latest filing, from -$41.7 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $134.4 million in Q1 2022 and bottomed at -$63.1 million in Q2 2024.
- Historically, Free Cash Flow has averaged -$39.6 million across 5 years, with a median of -$49.0 million in 2025.
- Annual changes were most pronounced in 2022 — Free Cash Flow soared 352.06% — and 2023, when it sank 136.35%.
- Alector's Free Cash Flow stood at -$46.1 million in 2022, then dropped by 0.51% to -$46.3 million in 2023, then slipped by 21.5% to -$56.3 million in 2024, then rose by 25.82% to -$41.7 million in 2025, then declined by 19.44% to -$49.8 million in 2026.
- Business Quant data shows ALEC's Free Cash Flow at -$49.8 million in Q1 2026, -$41.7 million in Q4 2025, and -$32.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.01 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 572.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -389.61 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 437.80 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2.33 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 477.44 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 292.04 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -95.09 Mn |
| 10 | Alector | 218.85 Mn | 46.05 Mn | - | -34.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -34.25 Mn |
| Jun 30, 2026 | -34.25 Mn |
| Mar 31, 2026 | -49.84 Mn |
| Mar 31, 2026 | -49.84 Mn |
| Dec 31, 2025 | -41.73 Mn |
| Dec 31, 2025 | -41.73 Mn |
| Sep 30, 2025 | -32.51 Mn |
| Sep 30, 2025 | -32.51 Mn |
| Jun 30, 2025 | -49.03 Mn |
| Jun 30, 2025 | -49.03 Mn |
| Mar 31, 2025 | -60.80 Mn |
| Mar 31, 2025 | -60.80 Mn |
| Dec 31, 2024 | -56.26 Mn |
| Dec 31, 2024 | -56.26 Mn |
| Sep 30, 2024 | -49.89 Mn |
| Sep 30, 2024 | -49.89 Mn |
| Jun 30, 2024 | -63.13 Mn |
| Jun 30, 2024 | -63.13 Mn |
| Mar 31, 2024 | -61.88 Mn |
| Mar 31, 2024 | -61.88 Mn |